by Elena Iemma | Jun 27, 2023 | Uncategorized
Developing biologics? EpiVax’s High Throughput Immunogenicity Assessment provides a comprehensive assessment of potential clinical immunogenicity for large sets of biologic candidates. This approach allows preclinical researchers to compare the immunogenic...
by Elena Iemma | Apr 4, 2023 | Uncategorized
The EpiVax team had a great time in Tokyo hosting the 15th annual Westin Immunogenicity Seminar! See pictures from the event below. Interested in attending the Westin Immunogenicity Seminar in 2024? Sign up here! The 15th annual 2023 Westin...
by Riley Nolan | Nov 18, 2022 | Uncategorized
A big THANK YOU to everyone who participated in the EpiVax’s 2022 Immunogenicity & Tolerance Seminar in Willemspark, Amsterdam, organized with Corine Kruiswijk of Intravacc. We learned about the importance of tissue-resident T memory cells, new developments in...
by Riley Nolan | Mar 24, 2022 | Featured, Thinking Out Loud -Blog, Uncategorized
Gene Therapies – time to think about Immunogenicity I just returned from the Gene Therapies for Rare Disorders meeting in Boston… and wow, what an exciting time for these therapies! Here’s a good overview of AAV therapies currently approved and in clinical trials for...
by Riley Nolan | Oct 20, 2020 | Uncategorized, Webinars
We are excited to share that our very own Annie De Groot was selected as a recipient of this year’s AAPS Global Health Award! View Annie’s acceptance speech here! The American Association of Pharmaceutical Scientists(AAPS) nominates one member annually for...
